{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:37:19Z","timestamp":1794440239375,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ebiom.2024.105414","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T05:12:11Z","timestamp":1729660331000},"page":"105414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Kotsamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Psarrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Dakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Thomas-R\u00fcddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Briegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Damoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7800-3306","authenticated-orcid":false,"given":"Panagiotis","family":"Koufargyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souzana","family":"Anisoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glykeria","family":"Vlachogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tsiantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Masullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Ioakeimidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eumorfia","family":"Kondili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ntaganou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gkeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassileios","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-1203","authenticated-orcid":false,"given":"Effie","family":"Polyzogopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin J.","family":"Reininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kiehntopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Mouloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-3514","authenticated-orcid":false,"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105414_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2016","article-title":"Interferon-\u03b3 and infectious diseases: lessons and prospects","volume":"384","author":"Casanova","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105414_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation-a traget for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ebiom.2024.105414_bib3","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s12094-023-03126-4","article-title":"Targeting CXCL9\/10\/11\u2013CXCR3 axis: an important component of tumor-promoting and antitumor immunity","volume":"25","author":"Pan","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ebiom.2024.105414_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113014","article-title":"CRISP-Cas9 secreening indentifies an IRF-SOCS-1-mediated negative feedback loop that limits CXCL9 expression and anitumor activity","volume":"42","author":"House","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2024.105414_bib5","first-page":"672","article-title":"Identification of CXCL9 chemokine as apotenital biomarker for assessing clinical severity in COVID-19 patients","volume":"18","author":"Ibadullaeva","year":"2024","journal-title":"J\u00a0Infect Dev Cntries"},{"key":"10.1016\/j.ebiom.2024.105414_bib6","first-page":"51","article-title":"CXCL9 and CXCL10 display an age-dependent profile in Chagas patients: a cohort study of aging in Bambui, Brazil","volume":"9","author":"Fortes de Ara\u00fajo","year":"2020","journal-title":"Infect Dis Prov"},{"key":"10.1016\/j.ebiom.2024.105414_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12916-017-0930-5","article-title":"Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis","volume":"15","author":"Kyriazopoulou","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.ebiom.2024.105414_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","article-title":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis","volume":"10","author":"Karakike","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2024.105414_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100817","article-title":"Towards personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.ebiom.2024.105414_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"\u03a4he third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105414_bib11","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/01.CCM.0000275271.77350.B6","article-title":"Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock","volume":"35","author":"Venet","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ebiom.2024.105414_bib13","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ebiom.2024.105414_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40635-022-00433-y","article-title":"Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation","volume":"10","author":"Anderko","year":"2022","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.ebiom.2024.105414_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0043-1761216","article-title":"Prognostic impact of the international society on Thrombosis and Hemostasis disseminated intravascular coagulation score in sepsis: a systematic review","volume":"49","author":"Frank","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ebiom.2024.105414_bib16","first-page":"662","article-title":"The hyperferritinemic syndromes and CD163: a marker of macrophage activation","volume":"16","author":"Colafrancesco","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ebiom.2024.105414_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067251","article-title":"ImmunoSep (personalised immunotherapy in sepsis) international double-blind, double-dummy, placebo-controlled randomized clinical trial: study protocol","volume":"12","author":"Kotsaki","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ebiom.2024.105414_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","article-title":"Redefining critical illness","volume":"28","author":"Maslove","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105414_bib19","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen activator receptor: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nature Med"},{"key":"10.1016\/j.ebiom.2024.105414_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ebiom.2024.105414_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10875-020-00950-z","article-title":"Biomarkers for early diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients","volume":"41","author":"Debaugnies","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.ebiom.2024.105414_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13054-023-04628-x","article-title":"Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric reseahc network: a causal inference analysis","volume":"27","author":"Fan","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2024.105414_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2019.03.018","article-title":"Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome","volume":"119","author":"Mizuta","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.ebiom.2024.105414_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39601-9","article-title":"CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis","volume":"13","author":"Diamond","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105414_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard-2022-223739","article-title":"Efficacy and safety of emapalumab in macrophage activation syndrome","volume":"82","author":"De Benedetti","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642400450X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642400450X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:39:09Z","timestamp":1732045149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642400450X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"alternative-id":["S235239642400450X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105414","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105414"}}